NATCO Pharma Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Key Metrics
PE ratio
10.14
PB ratio
1.83
Dividend yield
0.79%
Beta
0.12
Market cap
₹157.96B
Enterprise value
₹128.46B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 4199 |
| Website | https://www.natcopharma.co.in |
| Mailing address | Natco House Road No. 2 Banjara Hills Hyderabad 500034 India |
| Phone / Fax | 91 40 2354 7532 / 91 40 2354 8243 |
Dividends
Dividend yield
0.79%
Dividend amount
₹6.50
Payout ratio
5.75%
5Y Avg. yield
-%
NATCO Pharma Limited paid ₹6.50 dividend and the ex-dividend date was 18 Feb 2026.The dividend payout ratio is 5.75%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.NATCOPHARM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on NATCO Pharma Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. | MD & Chairman | 80 | |
| Mr. Rajeev Nannapaneni | CEO & Vice Chairman | 48 | |
| Mr. S. V. V. N. Appa Rao | Chief Financial Officer | ||
| Dr. Donthineni Linga Rao M.D. | President of Technical Affairs & Whole Time Director | 73 | |
| Mr. Chekuri Venkat Ramesh C.S. | Company Secretary & Compliance Officer | ||
| Mr. Potluri Sivaramakrishna Prasad | Executive VP of Corporate Engineering Services & Whole Time Director | 67 | |
| Nadella Malleswara Rao | VP & Head of Operations | ||
| Mr. Amit Parekh | Executive Vice President Finance & Accounts | ||
| N. Sadasiva Rao | Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management | ||
| James Rajakumar | Vice President of Marketing & Sales - Domestic |
Profitability and management effectiveness
Profit margin
34.13%
Operating margin
17.38%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of NATCO Pharma Limited is 157.96B and its enterprise value is 128.46B. The enterprise value to revenue ratio of NATCOPHARM is 2.81. The enterprise value to EBITDA ratio of NATCOPHARM is 7.20.
The NATCOPHARM's stocks Beta value is 0.12 making it 88% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
NATCO Pharma Limited (NSE:NATCOPHARM) Frequently Asked Questions
1. What is NATCO Pharma Limited's Stock Symbol?
NATCO Pharma Limited trades on NSE under the ticker symbol "NATCOPHARM".
2. What is NATCO Pharma Limited's stock price today?
One share of NATCOPHARM stock can currently be purchased for approximately ₹881.45.
3. How can I contact NATCO Pharma Limited?
NATCO Pharma Limited's mailing address is Natco House Road No. 2 Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 2354 7532.
4. What is NATCO Pharma Limited's official website?
The official website of NATCO Pharma Limited is https://www.natcopharma.co.in.